These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1490662)

  • 1. Normal hemodynamic and coagulation responses to 1-deamino-8-D-arginine vasopressin in a case of lithium-induced nephrogenic diabetes insipidus. Results of treatment by a prostaglandin synthesis inhibitor (indomethacin).
    Hober C; Vantyghem MC; Racadot A; Cappoen JP; Lefebvre J
    Horm Res; 1992; 37(4-5):190-5. PubMed ID: 1490662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic and coagulation responses to 1-desamino[8-D-arginine] vasopressin in patients with congenital nephrogenic diabetes insipidus.
    Bichet DG; Razi M; Lonergan M; Arthus MF; Papukna V; Kortas C; Barjon JN
    N Engl J Med; 1988 Apr; 318(14):881-7. PubMed ID: 2965301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normal response of factor VIII and von Willebrand factor to 1-deamino-8D-arginine vasopressin in nephrogenic diabetes insipidus.
    Brenner B; Seligsohn U; Hochberg Z
    J Clin Endocrinol Metab; 1988 Jul; 67(1):191-3. PubMed ID: 3132483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1-Desamino-8-D-arginine vasopressin (DDAVP) in patients with congenital nephrogenic diabetes insipidus.
    Brink HS; Derkx FH; Boomsma F; Brommer EJ; Schalekamp MA
    Neth J Med; 1993 Aug; 43(1-2):5-12. PubMed ID: 8232694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two distinct pathophysiological mechanisms in congenital nephrogenic diabetes insipidus.
    Moses AM; Miller JL; Levine MA
    J Clin Endocrinol Metab; 1988 Jun; 66(6):1259-64. PubMed ID: 3131381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desmopressin and indomethacin therapy for nephrogenic diabetes insipidus in patients receiving lithium carbonate.
    Weinstock RS; Moses AM
    South Med J; 1990 Dec; 83(12):1475-7. PubMed ID: 2123565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absent factor VIII response to synthetic vasopressin analogue (DDAVP) in nephrogenic diabetes insipidus.
    Kobrinsky NL; Doyle JJ; Israels ED; Winter JS; Cheang MS; Walker RD; Bishop AJ
    Lancet; 1985 Jun; 1(8441):1293-4. PubMed ID: 2860491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Water-balance hormones during long-term follow-up of oral dDAVP treatment in diabetes insipidus.
    Fjellestad-Paulsen A; Laborde K; Kindermans C; Czernichow P
    Acta Paediatr; 1993 Sep; 82(9):752-7. PubMed ID: 8241672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-dependent stimulation of renal prostaglandin synthesis by deamino-8-D-arginine vasopressin in rats with hereditary diabetes insipidus.
    Walker LA; Frölich JC
    J Pharmacol Exp Ther; 1981 Apr; 217(1):87-91. PubMed ID: 7205662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of renal prostaglandins during antidiuresis and water diuresis in man.
    Walker RM; Brown RS; Stoff JS
    Kidney Int; 1982 Feb; 21(2):365-70. PubMed ID: 6951096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lithium induced nephrogenic diabetes insipidus: changes in plasma vasopressin and angiotensin II.
    Padfield PL; Morton JJ; Lindop G; Timbury GC
    Clin Nephrol; 1975 Jun; 3(6):220-4. PubMed ID: 1139806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epinephrine and dDAVP administration in patients with congenital nephrogenic diabetes insipidus. Evidence for a pre-cyclic AMP V2 receptor defective mechanism.
    Bichet DG; Razi M; Arthus MF; Lonergan M; Tittley P; Smiley RK; Rock G; Hirsch DJ
    Kidney Int; 1989 Nov; 36(5):859-66. PubMed ID: 2559238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormonal and cardiovascular responses to DDAVP in man.
    Williams TD; Lightman SL; Leadbeater MJ
    Clin Endocrinol (Oxf); 1986 Jan; 24(1):89-96. PubMed ID: 3519005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular and renin responses to desmopressin in humans: role of prostacyclin and beta-adrenergic systems.
    Hasunuma K; Yamada K; Tamura Y; Yoshida S
    Am J Physiol; 1991 Apr; 260(4 Pt 2):H1031-6. PubMed ID: 1849368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of urine volume to the elevated urinary prostaglandin E in Bartter's syndrome and central and nephrogenic diabetes insipidus.
    Fichman M; Zia P; Zipser R
    Adv Prostaglandin Thromboxane Res; 1980; 7():1193-7. PubMed ID: 7369030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lithium-induced nephrogenic diabetes insipidus: studies of tubular function and pathogenesis.
    Rapoport J; Chaimovitz C; Alroy GG; Better OS
    Isr J Med Sci; 1979 Sep; 15(9):765-71. PubMed ID: 41818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normal response to DDAVP in patients with plathology of the hypothalamoneurohypophyseal axis.
    Vincente V; Corrales J; Miralles J; Alberca I
    Thromb Res; 1987 Mar; 45(5):695-7. PubMed ID: 3109066
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of vasopressin on prostaglandin excretion in conscious dogs.
    Fejes-Tóth G; Filep J; Mann V
    J Physiol; 1983 Nov; 344():389-97. PubMed ID: 6361236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidiuretic and PGE2 responses to AVP and dDAVP in subjects with central and nephrogenic diabetes insipidus.
    Moses AM; Scheinman SJ; Schroeder ET
    Am J Physiol; 1985 Mar; 248(3 Pt 2):F354-9. PubMed ID: 3856399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal prostaglandins and water balance: studies in normal volunteer subjects and in patients with central diabetes insipidus.
    Düsing R; Herrmann R; Glänzer K; Vetter H; Overlack A; Kramer HJ
    Clin Sci (Lond); 1981 Jul; 61(1):61-7. PubMed ID: 6265142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.